Marty Whalen
About Marty Whalen
Marty Whalen is the General Manager for the Europe Union and Nordic Cluster at Bristol Myers Squibb, based in Stockholm, Sweden. He has extensive experience in the pharmaceutical industry, having held various leadership roles at Bristol Myers Squibb and Pfizer.
Current Role at Bristol Myers Squibb
Marty Whalen currently serves as the General Manager for the Europe Union (EU) and Nordic Cluster at Bristol Myers Squibb. He is based in Stockholm, Sweden. His responsibilities include overseeing operations, implementing strategic initiatives, and driving growth across these regions.
Previous Roles at Bristol Myers Squibb
Before his current role, Marty Whalen held several key positions at Bristol Myers Squibb. From 2021 to 2022, he served as Vice President, Hematology, in Summit, New Jersey. He was also Vice President - Oncology Sales from 2018 to 2021 and Executive Director, Managed Care, from 2016 to 2018, both roles based in Princeton, New Jersey. Additionally, he was Regional Business Director, Oncology, from 2014 to 2016 in Plainsboro, New Jersey.
Experience at Pfizer
Marty Whalen has extensive experience at Pfizer. From 2012 to 2013, he was the Head of the Texas/Gulf Coast Market and served as Regional Marketing Lead in 2010. He was also State Director from 2009 to 2011 and Director of Cluster Operations, Managed Markets, for the U.S. in 2005. His other roles included Managed Markets Regional Manager from 2005 to 2008, Managed Care Account Manager from 2003 to 2005, District Sales Manager from 2000 to 2003, and Sales Representative and Regional Operations Manager from 1996 to 2000.
Academic Background
Marty Whalen holds a Master of Business Administration (MBA) in Business Administration and Management from The University of Texas at Dallas, where he studied from 2009 to 2010. He also earned a Bachelor of Science in Organizational Leadership from the United States Military Academy at West Point, completing his studies in 1994.
Professional Achievements
Throughout his career, Marty Whalen has led the launch of multiple oncology products in the European market, resulting in significant market share growth. He implemented a strategic initiative to improve operational efficiency across the EU and Nordic regions, achieving notable cost savings. He played a key role in integrating newly acquired companies into Bristol Myers Squibb's European operations and developed a comprehensive market access strategy for innovative therapies in the Nordic cluster. Marty actively mentors future leaders within the company and regularly participates in industry panels and conferences.